Aardvark Therapeutics (AARD) Interest & Investment Income (2024 - 2026)
Aardvark Therapeutics (AARD) reported Interest & Investment Income of $889000.0 for Q1 2026, down 24.34% on a YoY basis from $1.2 million in Q1 2025, and down 20.98% sequentially from $1.1 million in Q4 2025.
Aardvark Therapeutics (AARD) Interest & Investment Income (2024 - 2026) Analysis & Trends
Aardvark Therapeutics (AARD) has 3 years of Interest & Investment Income data on file, last reported at $889000.0 in Q1 2026.
- For the quarter ending Q1 2026, Interest & Investment Income fell 24.34% year-over-year to $889000.0; the trailing twelve-month figure through Mar 2026 stood at $4.9 million (up 39.21% YoY), and the FY2025 full-year result was $5.1 million, up 112.88% from the prior year.
- Interest & Investment Income slipped to $889000.0 in Q1 2026, from $1.1 million in the prior quarter.
- In the past five years, Interest & Investment Income ranged from a high of $1.5 million in Q2 2025 to a low of $103000.0 in Q1 2024.
- A 3-year average of $938000.0 and a median of $1.0 million in 2024 frame the typical range for Interest & Investment Income.
- Across the five-year window, Interest & Investment Income soared 1040.78% in 2025 and retreated 24.34% in 2026, its largest moves.
- Tracing AARD's Interest & Investment Income over 3 years: stood at $717000.0 in 2024, then jumped by 56.9% to $1.1 million in 2025, then fell by 20.98% to $889000.0 in 2026.
- Business Quant data shows AARD's Interest & Investment Income at $889000.0 in Q1 2026, $1.1 million in Q4 2025, and $1.4 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | 27.66 Mn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | 114.80 Mn |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | -65.80 Mn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | 48.00 Mn |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | 19.51 Mn |
| 10 | Aardvark Therapeutics | 143.99 Mn | 24.02 Mn | - | 889,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 889,000.00 |
| Dec 31, 2025 | 1.13 Mn |
| Sep 30, 2025 | 1.35 Mn |
| Jun 30, 2025 | 1.49 Mn |
| Mar 31, 2025 | 1.18 Mn |
| Dec 31, 2024 | 717,000.00 |
| Sep 30, 2024 | 1.00 Mn |
| Jun 30, 2024 | 594,000.00 |
| Mar 31, 2024 | 103,000.00 |